Medpace Holdings, Inc. MEDP

Company Overview

Medpace Holdings, Inc. is a global clinical contract research organization (CRO) that provides outsourced clinical development services to the pharmaceutical, biotechnology, and medical device industries. The company operates within the life sciences and healthcare services sectors, focusing primarily on supporting small- to mid-sized biotechnology firms in the development of drugs, biologics, and medical devices across multiple therapeutic areas.

Medpace’s core revenue is generated from providing end-to-end clinical trial services, including study design, regulatory strategy, clinical monitoring, data management, biostatistics, and medical writing. The company is known for its fully integrated service model, which differentiates it from many CRO peers that operate with more fragmented or outsourced service structures. Founded in 1992, Medpace evolved from a U.S.-based clinical services firm into a publicly traded global CRO following its initial public offering in 2016, with a strategic emphasis on organic growth rather than large-scale acquisitions.